Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
RH5.1/Matrix-M 是一种血液期疟疾候选疫苗，在坦桑尼亚健康成人和儿童中进行评估；这是一项开放标签、非随机、首次人体试验、单中心、1b期临床试验。
期刊:Lancet Infectious Diseases
影响因子:31
doi:10.1016/S1473-3099(24)00312-8
Silk, Sarah E; Kalinga, Wilmina F; Salkeld, Jo; Mtaka, Ivanny M; Ahmed, Saumu; Milando, Florence; Diouf, Ababacar; Bundi, Caroline K; Balige, Neema; Hassan, Omar; Mkindi, Catherine G; Rwezaula, Stella; Athumani, Thabit; Mswata, Sarah; Lilolime, Nasoro S; Simon, Beatus; Msami, Hania; Mohamed, Mohamed; David, Damiano M; Mohammed, Latipha; Nyaulingo, Gloria; Mwalimu, Bakari; Juma, Omary; Mwamlima, Tunu G; Sasamalo, Ibrahim A; Mkumbange, Rose P; Kamage, Janeth J; Barrett, Jordan R; King, Lloyd D W; Hou, Mimi M; Pulido, David; Carnrot, Cecilia; Lawrie, Alison M; Cowan, Rachel E; Nugent, Fay L; Roberts, Rachel; Cho, Jee-Sun; Long, Carole A; Nielsen, Carolyn M; Miura, Kazutoyo; Draper, Simon J; Olotu, Ally I; Minassian, Angela M
